$SURG
SurgePays, Inc.

2021 Q3 Form 10-Q Financial Statement

#000149315221028556 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3
Revenue $14.54M
YoY Change 13.56%
Cost Of Revenue $12.63M
YoY Change 12.65%
Gross Profit $1.903M
YoY Change 20.02%
Gross Profit Margin 13.09%
Selling, General & Admin $2.098M
YoY Change -27.76%
% of Gross Profit 110.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $181.1K
YoY Change -40.94%
% of Gross Profit 9.52%
Operating Expenses $2.279M
YoY Change -29.01%
Operating Profit -$375.9K
YoY Change -76.87%
Interest Expense -$1.418M
YoY Change 61.72%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$1.658M
YoY Change -33.74%
Income Tax
% Of Pretax Income
Net Earnings -$1.658M
YoY Change -33.74%
Net Earnings / Revenue -11.4%
Basic Earnings Per Share -$0.51
Diluted Earnings Per Share -$507.9K
COMMON SHARES
Basic Shares Outstanding 3.264M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $635.5K
YoY Change 50.84%
Cash & Equivalents $635.5K
Short-Term Investments
Other Short-Term Assets $35.00K
YoY Change -86.62%
Inventory $502.1K
Prepaid Expenses
Receivables $1.668M
Other Receivables $0.00
Total Short-Term Assets $2.840M
YoY Change 137.26%
LONG-TERM ASSETS
Property, Plant & Equipment $739.1K
YoY Change 10.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $411.1K
YoY Change -9.99%
Other Assets
YoY Change
Total Long-Term Assets $5.791M
YoY Change -10.37%
TOTAL ASSETS
Total Short-Term Assets $2.840M
Total Long-Term Assets $5.791M
Total Assets $8.631M
YoY Change 12.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.453M
YoY Change 279.63%
Accrued Expenses $68.30K
YoY Change 36.19%
Deferred Revenue
YoY Change
Short-Term Debt $2.919M
YoY Change 219.74%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.24M
YoY Change -6.07%
LONG-TERM LIABILITIES
Long-Term Debt $7.486M
YoY Change 122.81%
Other Long-Term Liabilities $447.0K
YoY Change -63.82%
Total Long-Term Liabilities $7.933M
YoY Change 72.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.24M
Total Long-Term Liabilities $7.933M
Total Liabilities $19.18M
YoY Change 15.76%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.55M
YoY Change
Total Liabilities & Shareholders Equity $8.631M
YoY Change 12.71%

Cashflow Statement

Concept 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.658M
YoY Change -33.74%
Depreciation, Depletion And Amortization $181.1K
YoY Change -40.94%
Cash From Operating Activities -$2.289M
YoY Change 99.64%
INVESTING ACTIVITIES
Capital Expenditures -$5.420K
YoY Change 313.74%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$5.410K
YoY Change -139.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.355M
YoY Change 93.93%
NET CHANGE
Cash From Operating Activities -2.289M
Cash From Investing Activities -5.410K
Cash From Financing Activities 2.355M
Net Change In Cash 60.70K
YoY Change -25.54%
FREE CASH FLOW
Cash From Operating Activities -$2.289M
Capital Expenditures -$5.420K
Free Cash Flow -$2.284M
YoY Change 99.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
USD
CY2020Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
USD
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 SURG Derivative Expense
DerivativeExpense
USD
CY2020Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
USD
CY2021Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
USD
CY2020Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
USD
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
CY2020Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
CY2021Q1 SURG True Up Adjustment Related To Initial Acquisition Of True Wireless
TrueUpAdjustmentRelatedToInitialAcquisitionOfTrueWireless
USD
CY2021Q3 SURG True Up Adjustment Related To Initial Acquisition Of True Wireless
TrueUpAdjustmentRelatedToInitialAcquisitionOfTrueWireless
USD
CY2021Q3 SURG Exercise Of Warrants
ExerciseOfWarrants
USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
USD
SURG Accounts Payable And Accrued Expenses Related Party One
AccountsPayableAndAccruedExpensesRelatedPartyOne
USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
USD
SURG Gain Contingency
GainContingency
USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
USD
SURG Repayment Of Notes Receivable
RepaymentOfNotesReceivable
USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
USD
SURG Proceeds From Sba Notes
ProceedsFromSbaNotes
USD
SURG Repayments On Sba Notes
RepaymentsOnSbaNotes
USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
SURG Deconsolidation Of Subsidiary True Wireless
DeconsolidationOfSubsidiaryTrueWireless
USD
SURG Stock Issued In Settlement Of Liabilities
StockIssuedInSettlementOfLiabilities
USD
SURG Conversion Of Debt Into Equity
ConversionOfDebtIntoEquity
USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
SURG Termination Of Ecs Rou Lease
TerminationOfEcsRouLease
USD
SURG Stock Issued For Acquisition Of Membership Interest In Ecs
StockIssuedForAcquisitionOfMembershipInterestInEcs
USD
us-gaap Stock Issued1
StockIssued1
USD
SURG Stock And Warrants Issued With Debt Recorded As Debt Discount
StockAndWarrantsIssuedWithDebtRecordedAsDebtDiscount
USD
CY2021Q2 SURG Notes Receivable Gross Due Remainder Of Fiscal Year
NotesReceivableGrossDueRemainderOfFiscalYear
USD
CY2021Q2 SURG Notes Receivable Gross Due In Next Twelve Months
NotesReceivableGrossDueInNextTwelveMonths
USD
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-202784 USD
CY2021Q3 SURG Derivative Expense
DerivativeExpense
USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
CY2019Q4 SURG Share Based Compensation Arrangement By Share Based Payment Award Options Un Vested And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnVestedAndExercisableNumber
shares
CY2019Q4 SURG Share Based Compensation Arrangement By Share Based Payment Award Options Unvested And Nonexercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedAndNonexercisable
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2019Q4 SURG Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable
shares
CY2019Q4 SURG Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Weighted Average Grant Date Fair Value Exercisable
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageGrantDateFairValueExercisable
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2020 SURG Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Weighted Average Grant Date Fair Value Exercise
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageGrantDateFairValueExercise

Files In Submission

Name View Source Status
0001493152-21-028556-index-headers.html Edgar Link pending
0001493152-21-028556-index.html Edgar Link pending
0001493152-21-028556.txt Edgar Link pending
0001493152-21-028556-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
surg-20210930.xsd Edgar Link pending
surg-20210930_cal.xml Edgar Link unprocessable
surg-20210930_def.xml Edgar Link unprocessable
surg-20210930_lab.xml Edgar Link unprocessable
surg-20210930_pre.xml Edgar Link unprocessable